ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Abdominal Radical Hysterectomy as an Alternative Treatment Option for Patients with Cervical Cancer without Access to Radiotherapy Facilities

Ye, Yanna; Li, Zhiqiang; Chen, Biliang; Kang, Shan; Ling, Bin; Wang, Li; Yao, Jilong; Lan, Jinghe; Liu, Ping*; Chen, Chunlin*东莞理工学院; 南方医科大学; 河北医科大学; 郑州大学; 中国医学科学院北京协和医院
Clinical and Experimental Obstetrics & Gynecology2023-10DOI: 10.31083/j.ceog5010219
11阅读
引用收藏
分享

摘要

Background: To compare the oncological outcomes of Chinese patients with International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIIC cervical cancer (CC) receiving radical chemoradiotherapy (R-CT), abdominal radical hysterectomy (ARH), or neoadjuvant chemotherapy and radical surgery (NACT). Methods: Overall, 4086 patients in 47 hospitals from 2004 to 2018 were divided into groups according to stage (4029 with stage IIIC1 and 57 with stage IIIC2). Kaplan-Meier and Cox regression analyses were applied to compare the 5-year overall survival (OS) and disease-free survival (DFS) of the three initial treatments before and after propensity score matching (PSM). Results: The 5-year DFS was worse in patients with stage IIIC2 than in those with stage IIIC1 (post-PSM: 68.3% vs. 39.9%, p < 0.001). For stage IIIC1, the ARH group had better 5-year OS (post-PSM: 71.0% vs. 80.0%, p < 0.001) and DFS (postPSM: 67.2% vs. 71.0%, p < 0.001) than the R-CT group, while the NACT group had worse 5-year DFS (post-PSM: 67.7% vs. 55.3%, p = 0.002). The 5-year OS (post-PSM: 80.9% vs. 70.5%, p < 0.001) and DFS (post-PSM: 70.7% vs. 54.1%, p < 0.001) were better in the ARH than in the NACT group. For stage IIIC2, the 5-year DFS was better in the ARH than in the NACT group (45.4% vs. 30.1%, p = 0.025). Conclusions: The oncological prognosis of patients with stage IIIC1 CC was generally better than that of patients with stage IIIC2, thereby supporting the rationale behind the classification of stage IIIC. In less developed areas, the ARH is a promising alternative treatment option for patients with stage IIIC; nonetheless, the use of NACT is not advisable.

学科与关键词

关键词
FIGO 2018 IIICcervical cancerradiotherapyprognosisabdominal radical hysterectomy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Clinical and Experimental Obstetrics & Gynecology
发表日期
2023-10
卷期
第 50 卷, 第 10 期
页码
5010219
DOI
10.31083/j.ceog5010219
语言
ENGLISH
成果收录
SCIE
资助标注
National Science and Technology Support Program of China [2014BAI05B03]; National Natural Science Fund of Guangdong [2015A030311024]; Dongguan Sci-tech Commissoner Program [20221800500661]; Guangdong Higher Vocational Education Teaching Reform Research and Practice Project [GDJG 2021008]; Science and Technology Plan of Guangzhou [158100075]

作者

  • Y

    Ye, Yanna (第一作者)

    southern med univ · dongguan polytech

  • L

    Li, Zhiqiang

    southern med univ

查看全部 10 位作者收起作者
  • C

    Chen, Biliang

  • K

    Kang, Shan

    hebei med univ

  • L

    Ling, Bin

    china japan friendship hosp

  • W

    Wang, Li

    zhengzhou univ

  • Y

    Yao, Jilong

  • L

    Lan, Jinghe

    southern med univ · peking union med coll hosp

  • L

    Liu, Ping (通讯)

    southern med univ

  • C

    Chen, Chunlin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417